Holen Sie sich die Stockscreener-App
3.29
1.86%
0.06
Schlusskurs vom Vortag:
$3.23
Offen:
$3.21
24-Stunden-Volumen:
2.98M
Relative Volume:
0.62
Marktkapitalisierung:
$876.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-252.18M
KGV:
-3.1038
EPS:
-1.06
Netto-Cashflow:
$-185.29M
1W Leistung:
-17.54%
1M Leistung:
-42.38%
6M Leistung:
+67.86%
1J Leistung:
+40.00%
1-Tages-Spanne:
$3.16
$3.3779
1-Wochen-Bereich:
$3.16
$3.98
52-Wochen-Spanne:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Firmenname
Sana Biotechnology Inc
Sektor
Branche
Telefon
(206) 701-7914
Adresse
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Vergleichen Sie SANA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.29 | 860.36M | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Wedbush | Outperform |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-03-18 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-11-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-01-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-08-14 | Eingeleitet | TD Cowen | Market Perform |
| 2023-05-02 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-03-01 | Eingeleitet | BofA Securities | Buy |
| 2021-03-01 | Eingeleitet | Goldman | Neutral |
| 2021-03-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-03-01 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
Why Sana Biotechnology Inc. stock could benefit from AI revolutionWatch List & Fast Gaining Stock Strategy Reports - newser.com
Can Sana Biotechnology Inc. stock deliver surprise earnings beat2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
How Sana Biotechnology Inc. stock benefits from global expansion2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Evaluating Sana Biotechnology Inc. with trendline analysisJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
What valuation multiples suggest for Sana Biotechnology Inc. stock2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
Using Ichimoku Cloud for Sana Biotechnology Inc. technicalsJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Will Sana Biotechnology Inc. stock benefit from automationBull Run & Daily Risk Controlled Trade Plans - newser.com
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care - FinancialContent
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength - Yahoo Finance
Can Sana Biotechnology Inc. recover in the next quarterTreasury Yields & Fast Exit and Entry Trade Guides - newser.com
Can Sana Biotechnology’s (SANA) Leaner Cost Structure Strengthen Its Long-Term Competitive Position? - Yahoo Finance
Sana Biotechnology Beats Expectations in Q3 Report - StocksToTrade
Identifying reversal signals in Sana Biotechnology Inc.Fed Meeting & Accurate Entry/Exit Alerts - newser.com
Why Sana Biotechnology Inc. stock is a must watch in 20252025 Geopolitical Influence & Risk Controlled Daily Trade Plans - newser.com
Sana Biotechnology Beats Earnings Expectations, Gains Investor Confidence - timothysykes.com
Is Sana Biotechnology Inc. stock a smart buy before Fed meetingWeekly Gains Report & Fast Exit and Entry Trade Guides - newser.com
Earnings visualization tools for Sana Biotechnology Inc.2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Sana Biotechnology’s Q3 Reports Beat Expectations, Stock Target Raised to $8 - StocksToTrade
Is Sana Biotechnology's (SANA) Ongoing Loss Reduction Shaping Its Long-Term Investment Narrative? - simplywall.st
Custom strategy builders for tracking Sana Biotechnology Inc.Gap Up & Safe Capital Allocation Plans - newser.com
Visual trend scoring systems applied to Sana Biotechnology Inc.2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
What MACD signals say about Sana Biotechnology Inc.July 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Long term hold vs stop loss in Sana Biotechnology Inc.Earnings Growth Summary & Stock Portfolio Risk Control - newser.com
Using economic indicators to assess Sana Biotechnology Inc. potentialJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
All You Need to Know About Sana (SANA) Rating Upgrade to Buy - sharewise.com
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):